Dr. Joel K. Braver, MD
- Medicare services, 2024
- 1,811
- Medicare patients, 2024
- 207
- Part D claims, 2024
- 112
- Publications
- 3
- Clinical trials
- 6
- Practice address
- 110 Rehill Ave, Somerville, NJ 08876
- Practice phone
- Call (908) 685-2200
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Braver's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Joel K. Braver is a radiation oncologist in Somerville, New Jersey
Dr. Braver practices at Robert Wood Johnson University Hospital Somerset in Somerville, New Jersey, part of RWJBarnabas Health.
Dr. Braver's NPI, 1891791174, was assigned on June 22, 2005. Dr. Braver graduated from Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc) in 1991. Dr. Braver holds New Jersey license 25MA06340800.
- NPI
- 1891791174NPI Registry (opens in a new tab)
- NPI enumeration date
- June 22, 2005
- NPI status
- Active
- Practice phone
- (908) 685-2200
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 61
- Medical school graduation
- 1991
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Joel K. Braver practices at Robert Wood Johnson University Hospital Somerset in Somerville, New Jersey
Dr. Braver's primary practice is Robert Wood Johnson University Hospital Somerset, at 110 Rehill Ave, Somerville, NJ 08876 in Somerset County. The practice phone is (908) 685-2200.
- Robert Wood Johnson University Hospital Somerset110 Rehill Ave, Somerville, NJ 08876 · Somerset CountyPhone(908) 685-2200
Source: Dmand AI Affiliation Data
Dr. Joel K. Braver is affiliated with 4 sites of care and 4 medical groups
Dr. Braver's primary practice is Robert Wood Johnson University Hospital Somerset in Somerville, New Jersey, part of RWJBarnabas Health. The medical group on file is Rutgers-RWJ Scleroderma Program. Dmand AI also links Dr. Braver to 3 more group practices and clinics and 3 medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Joel K. Braver's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Braver practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Robert Wood Johnson University Hospital Somerset | Available with a free account |
| +3 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across RWJBarnabas Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Joel K. Braver is one of 145 radiation oncologists in New Jersey
Radiation oncology is Dr. Braver's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Braver is licensed in New Jersey.
Specialties and state licenses
- Radiation oncology, New JerseyPrimary
Radiation oncologists near Dr. Braver
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Joel K. Braver billed Medicare for 1,811 services in 2024
CMS data shows 1,811 Medicare services from Dr. Braver across 19 procedure codes in 2024, for 207 Medicare patients. Medicare paid $131,920 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Braver's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Imaging
- 2023: 1,3762024: 1,4606%
- Office and hospital visits
- 2023: 1782024: 21119%
- Other services
- 2023: 02024: 140
Dr. Braver compared with the New Jersey median for radiation oncologists, 2024
- Dr. Braver
- New Jersey median
- Medicare services
- 1,811vs 1,813Close to median
- Medicare patients
- 207vs 210Close to median
- Part D claims
- 70vs 4652% above
Medians across 135 radiation oncologists in New Jersey with Dmand AI profiles that report each measure.
Dr. Braver's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Braver?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Braver and other radiation oncologists in New Jersey.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Joel K. Braver treated 207 Medicare patients in 2024, average age 76
CMS counts 207 Medicare patients who saw Dr. Braver in 2024. The largest group is 75 to 84, with 89 patients. 75% of them have cancer, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Braver's median patient age at 75, with 46% women.
Dr. Braver's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Braver's Medicare patients by sex, 2024
- Women11154%
- Men9646%
Chronic conditions among Dr. Braver's Medicare patients, 2024
- Cancer75%
- High blood pressure75%
- High cholesterol75%
- Arthritis44%
- Diabetes33%
- Ischemic heart disease31%
- Anxiety25%
- Mood disorders23%
Share of Medicare patients with each condition. A patient can have several.
Dr. Braver's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 75
Patient panel by sex, all payers
- Women46%
- Men53%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Joel K. Braver wrote 112 Medicare Part D claims in 2024
In 2024, Dr. Braver wrote 112 Medicare Part D claims for 60 patients. 96% of them were for generic drugs. CMS names the drug for 70 of them, across 2 drugs with 11 or more claims each, at $1,468 in total drug cost. In 2023, CMS named 83 claims across 2 drugs.
Dr. Braver's Part D claims by kind of drug, 2024
- Generic107 claims96%
- Brand-name and other5 claims4%
Dr. Braver's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 832024: 7016%
Drugs named by CMS: 2 in 2024, 2 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Joel K. Braver scored 88 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Braver for performance year 2024, reported as part of a group.
Dr. Braver's MIPS scores, performance year 2024
- 88of 100Final score
- 70.6of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Joel K. Braver has 3 publications on record
Dmand AI links 3 papers to Dr. Braver, published from 2018 to 2020. The most frequent topics are Radiotherapy Dosage and Radiotherapy Planning, Computer-Assisted. Dr. Braver's most frequent co-authors are Laura R. Bond, MD, Joseph Aisner and Dhiren S. Dave, MD.
Dr. Braver's papers by year, 2018 to 2020
Topics Dr. Braver writes about most
- Radiotherapy Dosage
- Radiotherapy Planning, Computer-Assisted
Dr. Braver's most frequent co-authors
Recent publications by Dr. Braver
Int J Radiat Oncol Biol Phys
See who Dr. Braver researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Braver works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Joel K. Braver has worked on 6 clinical trials
Dmand AI links Dr. Braver to 6 clinical trials, 2 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Lobular and Prostatic Neoplasms. NRG Oncology sponsors the most, 2.
Clinical trials with Dr. Braver by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 1Phase 2/3: 1 trial
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Braver's trials
- Breast Neoplasms
- Carcinoma, Lobular
- Prostatic Neoplasms
- Rectal Neoplasms
- Urinary Bladder Neoplasms
Investigators on the most trials with Dr. Braver
- Sinisa Stanic, MD4 shared trials
- Andrew Stuart Camarata, MD3 shared trials
- Shona T. Dougherty, MD, PhD3 shared trials
Recent clinical trials with Dr. Braver
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel (opens in a new tab)
Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/T4 Urothelial Bladder Cancer (opens in a new tab)
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients with Stage IIa-IIIa Breast Cancer (opens in a new tab)
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer (opens in a new tab)
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Joel K. Braver received $449 in industry payments from 2016 to 2024
CMS Open Payments shows 16 general payments to Dr. Braver from 15 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 81% of the total. Janssen Pharmaceuticals, Inc paid the most, $85.
General payments to Dr. Braver by program year, 2016 to 2024
General payments to Dr. Braver by kind, 2016 to 2024
- Food and beverage$36481%
- Education$8519%
Companies that paid Dr. Braver the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Joel K. Braver graduated from Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc)
Dr. Braver graduated from Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc) in 1991.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Joel K. Braver's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Joel K. Braver
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Joel K. Braver's NPI number?
Dr. Joel K. Braver's NPI number is 1891791174. It was assigned on June 22, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Joel K. Braver?
Dr. Joel K. Braver is a radiation oncologist in Somerville, New Jersey. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. Joel K. Braver practice?
Dr. Braver practices at 110 Rehill Ave, Somerville, NJ 08876. Dr. Braver's primary practice is Robert Wood Johnson University Hospital Somerset in Somerville, New Jersey, part of RWJBarnabas Health. Dmand AI also links Dr. Braver to 3 group practices and clinics and 3 medical groups.
What is Dr. Joel K. Braver's office phone number?
The practice phone on file for Dr. Braver is (908) 685-2200.
What is Dr. Joel K. Braver's medical license number?
Dr. Braver holds New Jersey license 25MA06340800.
Which hospitals is Dr. Joel K. Braver affiliated with?
Dr. Braver practices at Robert Wood Johnson University Hospital Somerset in Somerville, New Jersey.
What medical group is Dr. Joel K. Braver part of?
Dr. Braver is linked to Rutgers-RWJ Scleroderma Program. Dmand AI links Dr. Braver to 3 more medical groups.
Does Dr. Joel K. Braver accept Medicare?
Yes. CMS data shows Dr. Braver billed Medicare for 1,811 services in 2024.
What is Dr. Joel K. Braver's MIPS score?
Dr. Braver's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.
How many Medicare patients does Dr. Joel K. Braver see?
CMS counts 207 Medicare patients who saw Dr. Braver in 2024, with an average age of 76.
Show 7 more questionsShow fewer questions
What services does Dr. Joel K. Braver bill to Medicare?
In 2024, Dr. Braver's most billed Medicare services were radiation oncology (77014), radiation oncology (77427) and radiation oncology (77300).
Where did Dr. Joel K. Braver go to medical school?
Dr. Braver graduated from Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc) in 1991.
What drugs does Dr. Joel K. Braver prescribe most?
In 2024 Medicare Part D data, Dr. Braver's most prescribed drugs by claims were Mometasone Furoate and Tamsulosin HCl.
Has Dr. Joel K. Braver received payments from drug or device companies?
CMS Open Payments shows $449 in general payments to Dr. Braver from 15 companies from 2016 to 2024. The largest total came from Janssen Pharmaceuticals, Inc.
How long has Dr. Joel K. Braver been practicing?
Dr. Braver graduated from medical school in 1991, 35 years ago.
Does Dr. Joel K. Braver do research?
Dmand AI links 3 publications to Dr. Braver, published from 2018 to 2020. Dr. Braver has worked on 6 clinical trials.
Who does Dr. Joel K. Braver publish with?
Dr. Braver's most frequent co-authors are Laura R. Bond, MD (2 shared papers), Joseph Aisner (1 shared paper) and Dhiren S. Dave, MD (1 shared paper).
Selling to radiation oncology practices?
See radiation oncologists in New Jersey by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card